Clinical trials
Choroidal Neovascularization trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 7 |
| 2007 | 15 |
| 2008 | 9 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
| Terminated | 14 |
| Active, not recruiting | 6 |
| Unknown status | 4 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 10 |
| Novartis Pharmaceuticals | 6 |
| GlaxoSmithKline | 5 |
| Allergan | 4 |
| Johns Hopkins University | 4 |
| Ophthotech Corporation | 4 |
| Notal Vision Ltd. | 3 |
| AbbVie | 2 |
| Adverum Biotechnologies, Inc. | 2 |
| EyeBiotech Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Choroidal Neovascularization | 88 |
| Macular Degeneration | 72 |
| Wet Macular Degeneration | 10 |
| Eye Diseases | 7 |
| Retinal Diseases | 7 |
| Retinal Degeneration | 6 |
| Diabetic Retinopathy | 4 |
| Geographic Atrophy | 4 |
| Macular Edema | 4 |
| Inflammation | 3 |
Trials
Showing 26 to 50 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.